Abstract
We report 8 cases of persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia in patients previously treated with anti-CD20 monoclonal antibodies. Polymerase chain reaction of nasopharyngeal swabs for SARS-CoV-2 was negative in most cases; viral cell cultures confirmed that viable SARS-Co-2 virus was present. Four patients were treated with anti-SARS-CoV-2 hyperimmune globulins with rapid resolution of disease.
Original language | English |
---|---|
Article number | ofad464 |
Journal | Open Forum Infectious Diseases |
Volume | 10 |
Issue number | 10 |
DOIs | |
State | Published - 1 Oct 2023 |
Keywords
- COVID19
- SARS-CoV-2
- antibody therapy
- immune globulins
- monoclonal antibody
All Science Journal Classification (ASJC) codes
- Oncology
- Infectious Diseases